Results 101 to 110 of about 769 (122)

The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives. [PDF]

Curr Res Microb Sci
Souza CM, Bezerra BT, Mellon DA, de Oliveira HC.   +3 more
europepmc   +1 more source

An Update on Recent Clinical Trial Data in Bloodstream Infection. [PDF]

Antibiotics (Basel)
Stewart AG, Simos P, Sivabalan P, Escolà-Vergé L, Garnham K, Isler B, ESGBIES Study Group.   +6 more
europepmc   +1 more source

Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study. [PDF]

Open Forum Infect Dis
Hatzl S, Geiger C, Kriegl L, Reinisch A, Keldorfer M, Wölfler A, Wallner M, von Lewinski D, Eller P, Krause R.   +9 more
europepmc   +1 more source

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease. [PDF]

Clin Microbiol Rev
Hoenigl M, Arastehfar A, Arendrup MC, Brüggemann R, Carvalho A, Chiller T, Chen S, Egger M, Feys S, Gangneux J-P, Gold JAW, Groll AH, Heylen J, Jenks JD, Krause R, Lagrou K, Lamoth F, Prattes J, Sedik S, Wauters J, Wiederhold NP, Thompson GR.   +21 more
europepmc   +1 more source

New antifungal strategies and drug development against WHO critical priority fungal pathogens. [PDF]

Front Cell Infect Microbiol
Li Y, Liu Y, Jiang Y, Yang Y, Ni W, Zhang W, Tan L.   +6 more
europepmc   +1 more source

<i>Candida auris</i>: Epidemiology and Antifungal Strategy. [PDF]

Annu Rev Med
Eix EF, Nett JE.
europepmc   +1 more source

Detection and Management of Invasive Mold Disease in Pediatric Hematological Cancer Patients. [PDF]

Infect Drug Resist
Bochennek K, Rohm T, Lehrnbecher T.
europepmc   +1 more source